调节性T细胞/Th17细胞与免疫性血小板减少症被引量：2

下载PDF

导出

摘要特发性血小板减少性紫癜（idiopathicthrombocv．topenicpurpura。ITP）是一种以血小板免疫性破坏为特征的自身免疫病。目前认为，ITP患者除体液免疫功能紊乱。产生自身抗血小板抗体外．还存在Th1／Th2平衡失调，并以Th1反应占优势。Treg细胞与Th17细胞是最近发现的不同于Th1、Th2的新型CD4＋T细胞亚群．这两类细胞是否参与了ITP免疫异常发病过程，又是如何起作用，本文就此进行了综述。

作者郭宁红石庆之

机构地区南昌大学第二附属医院血液科

出处《江西医药》 CAS 2010年第1期65-67,共3页 Jiangxi Medical Journal

关键词紫癜血小板减少特发性 T淋巴细胞调节辅助

分类号 R558.2 [医药卫生—血液循环系统疾病]

引文网络
相关文献

参考文献24

1Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med, 2002, 346 (!3): 995.
2Sakaguchi S. Naturally arising Foxp3-exprcssing CD25+ CD4+ reg- ulatory T cells in immunological tolerance to self and non-self. Nat Immunol, 2005, 699(4):345.
3Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+regulatory T cells. Nat Immunol, 2003, (4): 330.
4Maloy KJ, Salaun L, Cahill R, et al. CD4+ CD25+T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. Exp Med, 2003, 197(1): 111.
5Balandina A, Lecart S, Dartevelle P, et al. Functional defect of reg- ulatory CD4+CD25+T cells in the thymus of patients with autoimmune myasthenia gravis. Blood, 2005, 105(2):735.
6Lin SC, Chen KH, Lin CH, et al. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest, 2007, 37(12):987.
7Jiao Z, Wang W, Jia R, et al. Accumulation of Foxp3-expressingCD4(+)CD25(+) T cells with distinct ehemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol, 2007, 36(6):428.
8Park H, Li Z, Yang XO, ctal. A distinct lineage of CD4+T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol, 2005, 6 (11): 1133.
9Ivanov II, Mekenzie BS, Zhou L, et al. The orphan nuclear receptor ROR-yt directs the differentiation program of pro.inflammatory IL- 17+ T helper cells. Cell, 2006, 126(6):1121.
10Kolls JK, Linden A. Interleukin-17 family members and inflammation. Inmmnity, 2004,21 (4):467.

二级参考文献26

1赵湜,王红祥,李菁媛,毛红,邹萍.调节性T细胞在慢性特发性血小板减少性紫癜中的作用[J].中华血液学杂志,2006,27(3):203-205. 被引量：17
2张之南忱悌.血液病诊断及疗效标准（第2版）[M].北京:科学出版社,1999.270-271.
3Cines DB ,McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med ,2005,56:425-442.
4McMillan R. Classical management of refractory adult immune ( idiopathic) thrombocytopenic purpura. Blood Rev,2002,16:51-55.
5Ahn YS, Horstman LL. Idiopathic thrombocytopenic purpura: pathophysiology and management. Int J Hematol, 2002,76 ( Suppl 2 ) : S123-S131.
6Lcvings MK,Sangrvgorio R,Roncarolo MG. Human cd25( + )cd4( + )t regulatory cells suppress naive and memory T cell proliferation and canbe expanded in vitro without loss of function. J Exp Med,2001,193 :1295-1302.
7Kuwana M, lkeda Y. The role of autoreactlve T-cells in the pathogenesis of idiopathic thrombocytopanic purpura. Int J Hematol, 2005,81 : 106- 112.
8Lan RY,Ansari AA,Lian ZX,et al. Regulatory T cells:development, function and role in autoimmunity. Autoimmun Rev,2005 ,4 :351-363.
9Setiady YY, Agersborg S, Samy ET, et al. Neonatal autoimmune disease: influence of CD4^+ CD25^+ regulatory T cells. Int Rev Immunol,2005,24: 227 -245.
10Sakaguchi S,Sakaguchi N. Regulatory T cells in immunologic serf-tolerance and autoimmune disease. Int Rev Immunol,2005 ,24 :211-226.